Case: Bristol-Myers Squibb Canada Co v Teva Canada Limited, 2017 FCA 76 (A-191-16), aff’g (for different reasons) 2016 FC 580 (Court File No. T-1364-14)
Drug: REYATAZ® (atazanavir bisulfate)
Nature of case: Appeal from application for prohibition order granted